https://www.thebodypro.com/category/hiv-treatments-in-development
HIV Treatment Strategies

HIV Treatments in Development

The Latest

healthcare dark
News

This Week in HIV Research: Delivering Care Through Uncertainty

Jan. 7, 2021: HIV status and COVID-19 disease severity; associations between tobacco smoking, cancer incidence, viral load, and CD4 count; immune recovery on integrase inhibitors; using smart pill bottles to boost adherence.

By Barbara Jungwirth and Myles Helfand
steps up
News

NIH Restructures HIV Clinical Trial Networks; AIDS Director Touts Milestones

“You could think of this as ‘who is in and who is out,’ but in reality [restructuring] is more like changing chairs,” said Carl Dieffenbach, Ph.D.

By Larry Buhl
green light
News

U.S. Waits on Approval of Long-Acting HIV Treatment Cabotegravir and Rilpivirine as European Union Gives the Green Light

The era of once-a-month HIV treatment has begun in the European Union—and it may soon commence in the U.S. as well. Long-acting pre-exposure prophylaxis (PrEP) is also on the horizon.

By Michael Broder
Promo Image
Features

Lenacapavir Is the Most Important HIV Antiretroviral You Won’t Find in PubMed

This year, we got exciting new data about an HIV drug in development that may become an every-six-month, self-administered antiretroviral injection. But we learned about it via press release, rather than carefully presented research.

By David Alain Wohl, M.D.
injection
Conference Coverage

Long-Acting Injectable HIV Treatment Still Appears Safe and Effective—and Largely Accessible Despite COVID-19 Disruptions

Research newly presented at the IDWeek 2020 conference yields further promising data on injectable cabotegravir/rilpivirine, as well as encouraging info regarding COVID-19 disruptions in treatment delivery.

By Larry Buhl
Ricardo Diaz
Conference Coverage

Researcher Behind "Brazil Patient," the Latest HIV Remission Case, Explains How It Happened

The international news story that broke at AIDS 2020, explained by the lead researcher.

By Terri Wilder, M.S.W.
Wakefield headshot.
Interviews

This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect

Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.

By Kenyon Farrow
injectable
Interviews

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.

By Terri Wilder, M.S.W.
Fauci discusses Remdesivir
News Analysis

We Need to Temper Expectations for Remdesivir as COVID-19 Treatment

Because the public is getting so many mixed messages, it’s our responsibility to provide clarity and moderate optimism.

By Kenyon Farrow
Shahin Lockman.
Interviews

Whether HIV or COVID-19, Pregnant or Lactating Cisgender Women Need to Be Included in Clinical Trials for Therapies

Dr. Shahin Lockman says to not include women in trials is unethical.

By Terri Wilder, M.S.W.